Internal Server Error

iDD - About the company

iDD is a seed company based in Gurugram (India), founded in 2009 by Yogesh Sharma, Patrick Benson, Ravi Rangasami, Karkavel Jegadesan and D T Arasu. It operates as a Provider of a cloud-based clinical drug development and clinical trial management software and services. iDD has raised $2.22M in funding from Millennium Medicare and Ebizzbox Online, with a current valuation of *****. The company has 302 active competitors, including 55 funded and 42 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.

Company Details

Provider of a cloud-based clinical drug development and clinical trial management software and services. The company has developed clinical trial amendment products as the iSmart that allows the users to remotely control, conduct, and collect data for drug development. The product is a wearable biosensor with technology that shows biometric data on the trial conducted on-site for analyzing the data on a real-time basis. The iPET is another tool developed by the company for patient enrollment and recruitment process.
Social
XFacebook
Email ID
*****@iddresearch.com
Phone Number
+1 **********
Registered Address
No.153, 6th street, Krishna Nagar, Tambaram West, chennai, Tamil Nadu, India, 600045
Key Metrics
Founded Year
2009
Location
Gurugram, India
Stage
Seed
Total Funding
$2.22M in 3 rounds
Latest Funding Round
Post Money Valuation
***** as on May 07, 2025
Ranked
Annual Revenue
₹20.9Cr as on Mar 31, 2025
Employee Count
101 as on Apr 30, 2026
Similar Companies
Sign up to download iDD's company profile

iDD's funding and investors

iDD has raised a total funding of $2.22M over 3 rounds. Its first funding round was on Apr 29, 2023. Its latest funding round was a Seed round on Dec 02, 2024 for $*****. 6 investors participated in its latest round. iDD has 11 institutional investors and 37 angel investors.

Here is the list of recent funding rounds of iDD:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Dec 02, 2024
7831072
Seed
9958140
4535042
5495046
1989477
Mar 29, 2024
4091075
Seed
3931443
6777190
2564094
Apr 29, 2023
8275877
Angel
6158486
6324482
6676438
9008002
lockAccess funding benchmarks and valuations. Sign up today!

iDD's founders and board of directors

Founder? Claim Profile
Here are the details of iDD's key team members:

iDD's employee count trend

iDD has 101 employees as of Apr 26. Here is iDD's employee count trend over the years:
Employee count trend for iDD
lockUncover iDD's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

iDD's Competitors and alternates

Top competitors of iDD include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of iDD, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Medidata
Medidata
1999, New York City (United States), Acquired
AI-based clinical trial management software for researchers
$41.5M
86/100
2nd
Logo for IQVIA
IQVIA
1982, Durham (United States), Public
Provider of clinical research and commercialization solutions for healthcare
$1.74M
80/100
3rd
Logo for Verily
Verily
2015, Dallas (United States), Series D
Developer of precision health platforms and solutions using artificial intelligence
$2.8B
79/100
4th
Logo for Tempus
Tempus
2015, Chicago (United States), Public
Developer of genomic sequencing and algorithmic diagnostic tools for medicine
$1.05B
74/100
5th
Logo for Signant Health
Signant Health
2000, Plymouth Meeting (United States), Acquired
Provider of a software solution for clinical trial management
$3.4M
72/100
6th
Logo for Science 37
Science 37
2014, Los Angeles (United States), Acquired
Provider of a suite solution for clinical trials for researchers
$106M
70/100
7th
Logo for Viz.ai
Viz.ai
2016, San Francisco (United States), Series D
Developer of an AI-powered platform for care coordination and disease detection
$252M
69/100
8th
Logo for TriNetX
TriNetX
2013, Cambridge (United States), Acquired
Provider of clinical trial management software for researchers and professionals
$102M
66/100
9th
Logo for BrightInsight
BrightInsight
2017, San Jose (United States), Series C
Provider of digital health solutions for clinical trials
$179M
64/100
10th
Logo for Wcg Clinical
Wcg Clinical
2012, Princeton (United States), Acquired
CRO offering regulatory and ethical review services for clinical research
-
64/100
33rd
Logo for iDD
iDD
2009, Gurugram (India), Seed
Provider of a cloud-based clinical drug development and clinical trial management software and services
$2.22M
48/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on iDD's competitors? Click here to see the top ones

iDD's Latest cap tables and shareholding

Founders (largest shareholder) own 66.69%, Funds own 2.47%, Enterprises own 5.11% and Angels own 15.05%. The net worth of iDD's founders is INR 134Cr as of May 07, 2025.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
66.69%
134Cr
5658264
9940142
1456645
8282791
4555794
1567182
8276804
9183629
8137228
8717240
2761776
7123495
2859759
6500387
3539359
9274836
Fund
2.47%
4.99Cr
64
11
53
71
Enterprise
5.11%
10.3Cr
84599
66043
41626
95264
Angel
15.05%
30.4Cr
9194411
7693129
9035136
3910543
0
0
0
0
0
0
4
1
1
4
6
1
Other People
9.24%
18.6Cr
6556544
6589861
9494075
1957532
ESOP Pool
1.43%
2.89Cr
2
5
1
4
Total
100.00%
202Cr
6425727
3164649
6552513
6071265
lockTo unlock detailed Cap Table of iDD Sign up today!
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
View more details of iDD's Shareholding

iDD's Investments and acquisitions

iDD has made no investments or acquisitions yet.

FAQs about iDD

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford